Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis. 1985

C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig

The pharmacokinetics of ceftizoxime (CZM) were determined in 16 non-infected CAPD patients. Patients received either 500 mg or 1000 mg CZM by i.v. bolus. The dialysate exchange volume was 2 l. Serum CZM concentrations at 10 min were 69.7 +/- 19.7 micrograms/ml (1000 mg dose) and 39.2 +/- 8.4 micrograms/ml (500 mg dose), and declined to 33.7 +/- 13.9 micrograms/ml and 16.9 +/- 3.2 micrograms/ml respectively at 360 min. Dialysate CZM levels at 10 and 360 min were 1.8 +/- 1.3 and 19.9 +/- 6.6 micrograms/ml respectively (1000 mg dose) and 1.4 +/- 0.9 and 12.6 +/- 3.5 micrograms/ml (500 mg dose). The half-time of CZM was 14.1 +/- 4.6 h. Peritoneal clearance of CZM was low and equilibrium was not achieved in 6 h. However peritoneal CZM concentrations were adequate within 1 h for the treatment of most organisms which cause CAPD-related peritonitis.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females

Related Publications

C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
August 1983, Antimicrobial agents and chemotherapy,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
November 1983, Clinical pharmacology and therapeutics,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
July 1987, The Journal of antimicrobial chemotherapy,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
December 1987, Clinical nephrology,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
January 1986, Nephron,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
September 1984, British journal of clinical pharmacology,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
January 1986, European journal of clinical pharmacology,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
January 1988, Clinical nephrology,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
May 2011, Clinical journal of the American Society of Nephrology : CJASN,
C A Johnson, and S W Zimmerman, and W Bayer, and W A Craig
January 1981, Clinical and experimental dialysis and apheresis,
Copied contents to your clipboard!